138 related articles for article (PubMed ID: 885638)
1. Measurement of fluoride in bone.
Mernagh JR; Harrison JE; Hancock R; McNeill KG
Int J Appl Radiat Isot; 1977 Jun; 28(6):581-3. PubMed ID: 885638
[No Abstract] [Full Text] [Related]
2. Applications of the whole-body counter in total-body neutron activation analysis.
Chamberlain MJ; Fremlin JH; Peters DK; Philip H
Br J Radiol; 1970 Apr; 43(508):287-8. PubMed ID: 5442507
[No Abstract] [Full Text] [Related]
3. Neutron activation studies and the effect of exercise on osteoporosis.
Harrison JE
J Med; 1984; 15(4):285-94. PubMed ID: 6597259
[TBL] [Abstract][Full Text] [Related]
4. New approach to the treatment of bone disease with fluoride.
Taves DR
Fed Proc; 1970; 29(3):1185-7. PubMed ID: 4910268
[No Abstract] [Full Text] [Related]
5. Aluminium in bone from patients with renal failure.
Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
[TBL] [Abstract][Full Text] [Related]
6. Partial-body calcium measurements by in vivo neutron activation analysis: comparisons with x-ray photodensitometry measurements of the radius.
Harrison JE; McNeill KG; Meema HE; Fenton S; Oreopoulos DG; Sturtridge WC
J Nucl Med; 1974 Nov; 15(11):929-34. PubMed ID: 4420966
[No Abstract] [Full Text] [Related]
7. Bone fluoride in patients with uremia maintained by chronic hemodialysis.
Kim D; Del Greco F; Hefferen JJ; Levin NW
Trans Am Soc Artif Intern Organs; 1970; 16():474-8. PubMed ID: 5454201
[No Abstract] [Full Text] [Related]
8. Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton.
Harrison JE; McNeill KG; Sturtridge WC; Bayley TA; Murray TM; Williams C; Tam C; Fornasier V
J Clin Endocrinol Metab; 1981 Apr; 52(4):751-8. PubMed ID: 6970749
[No Abstract] [Full Text] [Related]
9. Bone changes in end-stage oxalosis.
Brancaccio D; Poggi A; Ciccarelli C; Bellini F; Galmozzi C; Poletti I; Maggiore Q
AJR Am J Roentgenol; 1981 May; 136(5):935-9. PubMed ID: 6784531
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
Caniggia A; Vattimo A
Calcif Tissue Int; 1980; 30(1):5-13. PubMed ID: 6767533
[No Abstract] [Full Text] [Related]
11. Fluoride and nutritional osteoporosis: Physicochemical data on bones from an experimental study in dogs.
Henrikson PA; Lutwak L; Krook L; Skogerboe R; Kallfelz F; Bélanger LF; Marier JR; Sheffy BE; Romanus B; Hirsch C
J Nutr; 1970 Jun; 100(6):631-42. PubMed ID: 5453360
[No Abstract] [Full Text] [Related]
12. [New viewpoints on the physiology and toxocology of fluorides].
Hagen AR
Nor Tannlaegeforen Tid; 1967 Oct; 77(8):469-86. PubMed ID: 5235269
[No Abstract] [Full Text] [Related]
13. Fluoride treatment of bone rarefaction in multiple myeloma and osteoporosis. A review.
Cohen P; Nichols GL; Banks HH
Clin Orthop Relat Res; 1969; 64():221-49. PubMed ID: 4893445
[No Abstract] [Full Text] [Related]
14. Bone metabolism and its assessment in renal failure.
Coen G; Mazzaferro S
Nephron; 1994; 67(4):383-401. PubMed ID: 7969670
[No Abstract] [Full Text] [Related]
15. Effects of fluoride on bone in chronic renal failure.
Lough J; Noonan R; Gagnon R; Kaye M
Arch Pathol; 1975 Sep; 99(9):484-7. PubMed ID: 1164250
[TBL] [Abstract][Full Text] [Related]
16. Neutron activation analysis of a hand-a method of monitoring progressive bone disease.
McIntosh JA; Catto GR
Biomed Eng; 1974 Jun; 9(6):254-6 passim. PubMed ID: 4837582
[No Abstract] [Full Text] [Related]
17. The effect of fluoride alone or fluoride followed by calcium and vitamin D on disuse osteoporosis of the rat tail vertebrae.
Rosen D; Gedalia I; Anaise J; Simkin A; Arcan M
Calcif Tissue Res; 1975 Nov; 19(1):9-15. PubMed ID: 1081426
[TBL] [Abstract][Full Text] [Related]
18. Skeletal renewal and metabolic bone disease.
Harris WH; Heaney RP
N Engl J Med; 1969 Feb; 280(6):303-11 concl. PubMed ID: 4302928
[No Abstract] [Full Text] [Related]
19. Clinical investigation in metabolic bone disease. Quantitative measurements of bone mineral.
Evens RG; Pak CY; Ashburn W; Bartter FC
Invest Radiol; 1969; 4(6):364-9. PubMed ID: 5368348
[No Abstract] [Full Text] [Related]
20. Sodium fluoride in the treatment of osteoporosis.
Williams CC
Clin Invest Med; 1982; 5(2-3):195-7. PubMed ID: 6981483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
